Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis

By sjmartinez • November 2, 2024

Warren RB, Donnelly K, Kiri S, Taieb V, Slim M, Fahrbach K, Neupane B, Betts M, Armstrong A. Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis. Dermatol Ther (Heidelb). 2024 Nov 1. doi: 10.1007/s13555-024-01302-0. Epub ahead of print. PMID: 39485596.

Tags: adalimumab, bimekizumab, Dermatology, guselkumab, Long-term efficacy, Long-term safety, Network meta-analysis, psoriasis, Publications, risankizumab, secukinumab, ustekinumab

A New Twist on the Surgeon’s Knot: Quantifying Suture Security

Modiri O, Ebriani J, Sauvageau A, Davis J. A New Twist on the Surgeon's Knot: Quantifying Suture Security. Dermatol Surg. 2024 Nov 6. doi: 10.1097/DSS.0000000000004493.[...]

Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response

Santos P, Rezende CP, Piraine R, Oliveira B, Ferreira FB, Carvalho VS, Calado RT, Pellegrini M, Almeida F. Extracellular vesicles from human breast cancer-resistant cells[...]

Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients

Korouri E, Jeong C, Peterson H, Valenzuela F, Romiti R, Didaskalu JA, Egeberg A, Oon HH, Maul LV, Kingston P, Lee K, Huang MY, Yee[...]